DRKS00000632
Not yet recruiting
Not Applicable
Identification of exacerbation markers in chronic inflammatory airway diseases
Forschungszentrum BorstelLaborgruppe Mukosaimmunologie0 sites120 target enrollmentApril 4, 2011
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- J45
- Sponsor
- Forschungszentrum BorstelLaborgruppe Mukosaimmunologie
- Enrollment
- 120
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Status of the donor:
- •a) confirmed chronic inflammatory airway disease (asthma or COPD) or
- •b) infection of the upper airways in the absence of a chronic inflammatory airway disease or
Exclusion Criteria
- •The patient is not able to give his/her informed consent. The patient is in any relationship of dependency with the participating institutions
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Exacerbation indicators in patients with noninvasive home ventilatioJ44.0J96.11Chronic obstructive pulmonary disease with acute lower respiratory infectionDRKS00029273Kliniken der Stadt Köln gGmbH, Lungenklinik Standort-Merheim85
Not yet recruiting
Not Applicable
Exploratory study of exacerbation detection using respiratory stability time in COVID-19 patientsJPRN-jRCT1052200163Sawa Yoshiki65
Completed
Not Applicable
Identification of predictive biomarkers for severe progression of COVID-19U07.1COVID-19, virus identifiedDRKS00021591Bundeswehrkrankenhaus Berlin, Klinik I (Innere Medizin)135
Recruiting
Not Applicable
nreported symptomatic exacerbation and progressive pulmonary fibrosis in patients with interstitial lung disease: prospective observational study using a disease management system (YaDoc)Interstitial Lung DiseaseJPRN-UMIN000049420Tosei General Hospital40
Recruiting
Not Applicable
Biomarker study for exacerbation predictive markers in patients with COVID-19COVID-19JPRN-UMIN000044212Kanazawa University200